Stock listing

Laboratorios Farmaceuticos Rovi, S.a.

Selected listing: 41L · BX · CHF · CH

Laboratorios Farmaceuticos Rovi, S.a. (BX Swiss: 41L), Health Technology. Latest release Jul 23, 2026: Laboratorios Farmaceuticos Rovi S A : First half 2026…

41L:BXCHFCHUpdated October 3, 2026

Ticker: BX Swiss: 41L
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BX Swiss
Currency: CHF

Latest news from Laboratorios Farmaceuticos Rovi, S.a.

Laboratorios Farmaceuticos Rovi S A : First half 2026 results press release

July 23, 2026

Laboratorios Farmaceuticos Rovi S A : ROVI and the Regional Government of Castilla-La Mancha promote a framework of collaboration to modernise healthcare services through technological innovation

July 8, 2026

Laboratorios Farmaceuticos Rovi S A : First three months of 2026 results press release

May 6, 2026

Laboratorios Farmaceuticos Rovi S A : 2025 results press release

February 25, 2026

Laboratorios Farmaceuticos Rovi S A : ROVI releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development

November 18, 2025

All Laboratorios Farmaceuticos Rovi, S.a. news →

Events

Replays

Laboratorios Farmaceuticos Rovi, S.A. (0ILL) Q1 2026 Earnings Call
Wed, May 06, 2026 · 05:00 AM ET
Watch

Research Laboratorios Farmaceuticos Rovi, S.a.

Laboratorios Farmaceuticos Rovi, S.a. company profile

View the public company page for Laboratorios Farmaceuticos Rovi, S.a. on 6ix.

Laboratorios Farmaceuticos Rovi, S.a. news

Read company news and market updates connected to Laboratorios Farmaceuticos Rovi, S.a..

Laboratorios Farmaceuticos Rovi, S.a. investor events

Find investor webinars, events, and replay context for Laboratorios Farmaceuticos Rovi, S.a..